Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity

Jen Chywan Wang, Nilesh Shah, Carlos Pantoja, Sebastiaan H. Meijsing, Joseph D. Ho, Thomas S. Scanlan, Keith R. Yamamoto

Research output: Contribution to journalArticlepeer-review

80 Scopus citations

Abstract

The activities of intracellular receptors are regulated by their cognate ligands. Here we show that a series of related arylpyrazole compounds, which specifically bind the glucocorticoid receptor (GR), selectively modulated GR-regulated biological functions in preadipocyte, preosteoblast, and lung epithelial cell lines. Indeed, when we monitored 17 endogenous GR target genes in one of these cell types, we found that distinct arylpyrazole compounds induced different expression patterns. We showed by chromatin immunoprecipitation that the arylpyrazole compounds regulated, in a gene-specific manner, either GR occupancy of the genomic glucocorticoid response element (GRE) or events after GR association, such as histone modification. Overall, our results establish that subtle differences in ligand chemistry can profoundly influence the transcriptional regulatory activity of GR, and that endogenous genes bearing natural GREs are especially sensitive detectors of these differences.

Original languageEnglish (US)
Pages (from-to)689-699
Number of pages11
JournalGenes and Development
Volume20
Issue number6
DOIs
StatePublished - Mar 15 2006
Externally publishedYes

Keywords

  • Arylpyrazole compounds
  • Chromatin immunoprecipitation
  • Glucocorticoid receptor
  • Glucocorticoid receptor ligand
  • Response element

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity'. Together they form a unique fingerprint.

Cite this